Changes in lung function in young cystic fibrosis patients between two courses of intravenous antibiotics against pseudomonas aeruginosa

Pediatric Pulmonology

Volumn 44, Issue 5, 2009, Pages 464-471

  Béghin, Laurent ^a,b,f   Michaud, Laurent ^a,c   Loeuillé, Guy Andre ^d   Wizla Derambure, Nathalie ^a,c   Sayah, Hocine ^b   Sardet, Anne ^e   Thumerelle, Caroline ^c   Deschildre, Antoine ^c   Turck, Dominique ^a,c   Gottrand, Frédéric ^a,c  

^a UNIV LILLE   (France)

^b University of Lille   (France)

^c LILLE UNIVERSITY HOSPITAL   (France)

^d Dunkerque General Hospital   (France)

^e University of Lens   (France)

^f Clinique de Pediatrie   (France)

Author keywords

Antibiotic therapy; Body composition; Cystic fibrosis; Lung function; Nutritional status; Pseudomonas aeruginosa

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; ANTIBIOTIC AGENT; BETA LACTAM ANTIBIOTIC; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ADOLESCENT; ADULT; ANTIBIOTIC SENSITIVITY; ARTICLE; BODY COMPOSITION; CALORIC INTAKE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; LUNG FIBROSIS; LUNG FUNCTION TEST; MALE; NUTRITIONAL STATUS; PHYSICAL ACTIVITY; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; SCHOOL CHILD;

ADOLESCENT; ANTI-BACTERIAL AGENTS; CHILD; CYSTIC FIBROSIS; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; INFUSIONS, INTRAVENOUS; LUNG; MALE; NUTRITIONAL STATUS; PROSPECTIVE STUDIES; PSEUDOMONAS INFECTIONS; RESPIRATORY FUNCTION TESTS; RESPIRATORY TRACT INFECTIONS; YOUNG ADULT;

EID: 66749160296     PISSN: 87556863     EISSN: 10990496     Source Type: Journal    
DOI: 10.1002/ppul.21017     Document Type: Article

References (36)

1. FitzSimmons SC. The changing epidemiology of cystic fibrosis. J Pediatr 1993;123:1 -9.
2. Steinkamp G, Tummler GB, Malottke R, Von der HH. Treatment of Pseudomonas Aeruginosa colonisation in cystic fibrosis. Arch Dis Child 1988;64:1022-1028.
3. Cystic fibrosis foundation. Patient registry 1999 annual report. 2000.
4. Steinkamp G, Tummler B, Gappa M, Albus A, Potel J, Doring G, Von den hardt H. Long-term tobramycin aerosol therapy in cystic fibrosis. Pediatr Pulmonol 1989;6:91 -98.
5. Vic P, Ategbo S, Gottrand F, Launay V, Loeuille GA, Elian JC, Druon D, Farriaux JP, Turck D. Nutritional impact of anti- pseudomonas intravenous antibiotic courses in cystic fibrosis. Arch Dis Child 1997;76:437-440.
6. Fernandes B, Plummer A, Wildman M. Duration of intravenous antibiotic therapy in people with cystic fibrosis. Cochrane Database Syst Rev 2008;2:CD006682.
7. Konstan MW, Morgan WJ, Butler SM, Pasta DJ, Craib ML, Silva SJ, Stock DC, Whole ME, Wagener JS, Regelmann WE, Johnson CA, Scientific Advisory Group and the Investigators and Coordinators of the Epidemiologic Study of Cystic Fibrosis. Risk factors for rate of decline in forced expiratory volume in one second in children and adolescents with cystic fibrosis. J Pediatr 2007;151:134-139.
8. Cunningham S, McColm JR, Mallinson A, Boyd I, Marshall TG. Duration of effect of intravenous antibiotics on spirometry and sputum cytokines in children with cystic fibrosis. Pediatr Pulmonol 2003;36:43 -48.
9. Smith AL. Antibiotic therapy in cystic fibrosis: evaluation of clinical trials. J Pediatr 1986;108:866-870.
10. Shwachman H, Kulczycki L. Long-term study of one hundred five patients with cystic fibrosis. Am J Dis Child 1958;96:6-15.
11. Li Z, Kosorok MR, Farrell PM, Laxova A, West SE, Green CG, Collins J, Rock MJ, Splaingard ML. Longitudinal development of mucoid Pseudomonas aeruginosa infection and lung disease progression in children with cystic fibrosis. JAMA 2005;293:581 -588.
12. French Pediatric Society. Consensus on the management of the cystic fibrosis patient. French Pediatr Soc 2008;1:54-64.
13. Doring G, Conway SP, Heijerman HG, Hodson ME, Hoiby N, Smyth A, Thouw DJ. Antibiotic therapy against Pseudomonas aeruginosa in cystic fibrosis: a European consensus. Eur Respir J 2000;16:749-767.
14. Schaefer F, Georgi M, Zieger A, Scharer K. Usefulness of bioelectric impedance and skinfold measurements in predicting fat-free mass derived from total body potassium in children. Pediatr Res 1994;35:617-624.
15. Dodge JA, O'Rawe AM. Energy requirements in cystic fibrosis. In: Dodge JA, Brock DJH, Widdicombe JH, editors. Cystic fibrosis-Current topics. Chichester: John Wiley & Sons; 1994. pp. 235-254.
16. Durnin JV, Rahaman MM. The assessment of the amount of fat in the human body from measurements of skinfold thickness. Br J Nutr 1967;21:681 -689.
17. Quirk PC, Ward LC, Thomas BJ, Holt TL, Shepherd RW, Cornish BH. Evaluation of bioelectrical impedance for prospective nutritional assessment in cystic fibrosis. Nutrition 1997;13:412-416.
18. Rowlands AV, Thomas PW, Eston RG, Topping R. Validation of the RT3 triaxial accelerometer for the assessment of physical activity. Med Sci Sports Exerc 2004;36:518-524.
19. Informatic Center for Quality of foods. In: INSERM, Editor. Pictures of differents meals. Paris: INSERM; 1993; pp. 1 -63.
20. AFSAA, CIQUAL, Maisons-Alfort. French Food Composition Data base. REGAL 2007.
21. Chattaway FW, Happold FC, Happold AM. Nutrition of school children in Leeds. Br Med J 1946;1:429-435.
22. Mortimer KM, Fallot A, Balmes JR, Tager IB. Evaluating the use of a portable spirometer in a study of pediatric asthma. Chest 2003;123:189 -907.
23. Rebuck DA, Hanania NA, D'Urzo AD, Chapman KR. The accuracy of a handheld portable spirometer. Chest 1996;109:152-157.
24. Lung function testing selection of reference values and interpretative strategies. American Thoracic Society. Am Rev Respir Dis 1991;144:1202-1218.
25. 25.Vic P, Ategbo S, Turck D, Husson MO, Tassin E, Loeuille G, Deschildre A, Druon D, Elian JC, Arrouet-Lagandre C, Farriaux JP. Tolerance, pharmacokinetics and efficacy of once daily amikacin for treatment of Pseudomonas aeruginosa pulmonary exacerbations in cystic fibrosis patients. Eur J Pediatr 1996;155:948-953.
26. Murphy AJ, Buntain HM, Wainwright CE, Davies PS. The nutritional status of children with cystic fibrosis. Br J Nutr 2006; 95:321 -324.
27. Schaedel C, de Monestrol I, Hjelte L, Johannesson M, Kornfalt R, Lindblad A, Strandvik B, Wahlgren L, Holmberg L. Predictors of deterioration of lung function in cystic fibrosis. Pediatr Pulmonol 2002;33:483-491.
28. Yi MS, Britto MT, Wilmott RW, Kotagal UR, Eckman MH, Nielson DW, Kociela VL, Tsevat J. Health values of adolescents with cystic fibrosis. J Pediatr 2003;142:133-140.
29. Ionescu AA, Nixon LS, Luzio S, Lewis-Jenkins V, Evans WD, Stone MD, Owens DR, Routlgege PA, Shale DJ. Pulmonary function, body composition, and protein catabolism in adults with cystic fibrosis. Am J Respir Crit Care Med 2002;165:495-500.
30. Corey M, McLaughlin FJ, Williams M, Levison H. A comparison of survival, growth, and pulmonary function in patients with cystic fibrosis in Boston and Toronto. J Clin Epidemiol 1988; 41:583-591.
31. Sinaasappel M, Stern M, Littlewood J, Wolfe S, Steinkamp G, Heijerman HG, Robberecht E, Do ring G. Nutrition in patients with cystic fibrosis: a European Consensus. J Cyst Fibros 2002; 1:51 - 75.
32. Levy LD, Durie PR, Pencharz PB, Corey ML. Effects of long- term nutritional rehabilitation on body composition and clinical status in malnourished children and adolescents with cystic fibrosis. J Pediatr 1985;107:225-230.
33. Groeneweg M, Tan S, Boot AM, de Jongste JC, Bouquet J, Sinaasappel M. Assessment of nutritional status in children with cystic fibrosis: conventional anthropometry and bioelectrical impedance analysis. A cross-sectional study in Dutch patients. J Cyst Fibros 2002;1:276-280.
34. Mc Closkey M, Redmond AO, Mc Cabe C, Pyper S, Westerterp KR, Elborn SJ. Energy balance in cystic fibrosis when stable and during a respiratory exacerbation. Clin Nutr 2004;23:1405-1412.
35. Pedreira CC, Robert RG, Dalton V, Oliver MR, Carlin JB, Robinson P, Cameron FJ. Association of body composition and lung function in children with cystic fibrosis. Pediatr Pulmonol 2005;39:276-280.
36. Termoz A, Touzet S, Bourdy S, Decullier E, Bouveret L, Colin C, Nove-Josserand R, Reix P, Cracowski C, Pin I, Bellon G, Durieu I. Effectiveness of home treatment for patients with cystic fibrosis: the intravenous administration of antibiotics to treat respiratory infections. Pediatr Pulmonol 2008;43:908-915.